Journal ArticleAuthors : Bennett, Grace M. (2023)
Aberrant cellular phosphorylation is a hallmark of several diseases including inflammation and
cancers (1–3). Protein phosphorylation is a post-translational modification that can act as a
switch to regulate biochemical pathways and is regulated by the concerted action of two classes
of enzymes: kinases and phosphatases. As such, kinases and phosphatases present as
significant potential clinical molecular targets. To date, several kinase inhibitors have...